Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think thats wrong on fintel. Secondly, if he sold today (according to fintel) then a new 13G will be filed. You are talking about 1-2 months older 13G.
I checked his portfolio again and it shows he is still holding it.
I'm not sure if it's correct information cus when you see Woodford's portfolio, it shows he sold on March 31,2017 where as this page (https://fintel.io/so/us/nwbo) shows that he sold it today.
Can someone please confirm it asap?
https://fintel.io/so/us/nwbo
8K will be out today if I'm not wrong.
We are in deep sh*t!!!!!
Woodford sold his shares!
That's a great buy volume after 12pm ! Looks like someone is accumulating.
I see institutional sales on fintel.io , I guess financing coming soon (that's what happened last time). GL
Simply amazing ! yesterday and today volume is 2:1 and we are still red. So they think we cant see what they are doing !
We might have news today. No volume today and samething happened last time when they raised the money (High vol. on Mon followed by lil vol. on Tue).
GL
Short vol is 17.14% today so they're manipulating the SP w/o shorting it.
Buy and sell vol is almost 2:1 and the price is still going down.
Speechless!
I believe finra updates short interest after 15-20 days but shortotc as well as shortvolume.com updates daily so even it's from third party source, shouldnt be a big difference.
Woah ! 72% short volume today , looks like PPS will go down soon.
Oh Milner my buddy where have you been whole day? Missed you man !
Smart money will load up now,if you now what I mean! GL
Shorts still pulling it down ! 3M outta 5.7M shares shorted today with a short interest of 55.25%, who the hell is shorting heavily?!
I feel you and I dont see $ going up. My luck never works lol.
heavy shorting since last two days(55% & 60%) followed by short covering today ,dropping the short interest to 16.37% today.
oh well that's the requirement of entering into the ASCO(to have an abstract). Just curious no one found it!
so no abstract title of NWBO? How can they be in ASCO without abstract title...hmmmm
Correct me if I'm wrong.
They cant do dilution until May 23rd unless the price is above 0.43, however non-institutional investors can buy the shares.
(Section 4.13 in this filing)
https://www.sec.gov/Archives/edgar/data/1072379/000114420417016300/v462081_ex10-1.htm
yeah andy biotech twitted some of the titles, dunno how he got them.
Release of abstract title is due tomorrow.
https://am.asco.org/abstracts
If there's one more dilution, which is soon else they find a way out to get the money then I believe R/S coming soon!
GL
But she is good at raising money quietly lol
She can't and she doesn't have the will to do cus that's the reality!
For example:If cops arrest you and you haven't done any crime, wouldn't you screw them over? :)
Where is flipper and rest of them who used to be bash me? They must be regretting now lol better listen!
Where are all die hard longs now? They always wanna defend the mgmt,now defend it and take 0.10 lol
Definitely shorts are scared thats why we are at 0.18 LOL
Something is cooking up, very low volume today.
we might get 10K/news next week.
GL
Still $1 rule applies and it doesnt apply on OTC that's why all garbage/P&D stocks are on OTC exchange.
GL
Why do I see so many posts about R/S? I like it when people are "over confident".
After R/S ,are you guys gonna start talking about BK?LOL
If no news soon then we'll be below $0.20 in 1-2 weeks. :(
GL
Would have been better if they wont have released 8k ! lol
Technically, we might see $0.45 soon cus I believe they need $5.7M for the payment in June,2017. They need to pump the price to raise money:)
Load up the truck lol
No data soon. We might see $0.45 soon and then dilution!
4.17 PFS Data. The Company covenants that the Company, any Subsidiary, or any employee, agent or Affiliate of the Company or any Subsidiary shall not release or publicly disclose any PFS data of the Company or any Subsidiary before the sixty-first (61st) day anniversary of the Closing Date.
4.13 Subsequent Equity Sales.
(a) From the date hereof until 60 days after the Closing Date, neither the Company nor any Subsidiary shall issue, enter into any agreement to issue or announce the issuance or proposed issuance of any shares of Common Stock or Common Stock Equivalents, other than Exempt Issuances; provided, however, that notwithstanding the foregoing, if the VWAP of the Common Stock is reported on any Trading Market above forty-five cents ($0.45) for at least three (3) consecutive Trading Days, then neither the Company nor any Subsidiary shall thereafter be bound by the obligations set forth in this Section 4.13.
Haven't read it yet but I came across this post
insert-text-here
Just realized they released 8k today. Anyone read it?
Is NWBO next Dendreon?
The manufacturing of our product candidates will have to be greatly scaled up for commercialization, and neither we nor other parties in the industry have experience with such scale-up.
As is the case with any clinical trial, our Phase III clinical trial of DCVax-L for GBM involves a number of patients that is a small fraction of the number of potential patients for whom DCVax-L may be applicable in the commercial market. The same will be true of our other clinical programs with our other DCVax product candidates. If our DCVax-L, and/or other DCVax product candidates, are approved for commercial sale, it will be necessary to greatly scale up the volume of manufacturing, far above the level needed for the trials. Neither we nor our contract manufacturers have experience with such scale-up. In addition, there are very few consultants or advisors in the industry who have such experience and can provide guidance or assistance, because active immune therapies such as DCVax are a fundamentally new category of product in two major ways: these active immune therapy products consist of living cells, not chemical or biologic compounds, and the products are personalized. To our knowledge, no such products have successfully completed the necessary scale-up for commercialization without material difficulties. For example, Dendreon Corporation has encountered substantial difficulties trying to scale up the manufacturing of its Provenge® product for commercialization.[color=red][/color]
Impressive that short vol. was quite low today.
Can anyone see how many short shares are available for NWBO?
Just want to get an idea, not shorting it lol :)